Long-run onco-functional outcomes following mapping-guided supratotal resection in awake patients with IDH-mutated grade 2 gliomas
Preliminary results suggested a benefit of supratotal resection (SupTR) in grade 2 gliomas (G2G). However, long-term results are lacking in the molecular era. Here, long-run onco-functional outcomes are investigated following functional-guided SupTR of G2G. Patients who underwent awake mapping-based SupTR (additional resection margin beyond the presurgical FLAIR hypersignal) for IDH-mutated G2G were selected. Patients with no recurrence were compared to patients with tumor relapse that led to new treatment(s). This consecutive experience comprised 55 patients (29 men [52.7%], mean age 38.2 ± 10.4 years) with incidental discovery in 35 cases (63.6%) and epilepsy in 20 cases (36.4%). The mean KPS score was 98.4 ± 4.6 with 49 working patients (89%). The mean preoperative tumor volume was 14.1 ± 11.5 cc. All resections were continued up to functional networks identified by cortico-axonal stimulation in awake patients. There was no postoperative permanent impairment. The mean postoperative KPS score was 97.4 ± 5.2, with 47/49 patients who returned to work (95.9%). There were 30 IDH-mutated astrocytomas (54.5%) and 25 oligodendrogliomas (45.5%). No early adjuvant therapy was administered. During the follow-up, due to tumor relapse in 23 patients (41.8%), 19 of them underwent reoperation(s) and 9 had chemotherapy (including 3 with radiotherapy). The time to next intervention was 5.7 years (range 0.9–15.3). With a median follow-up of 9 years (range 0.3–23.3), the median OS was not reached (one patient died). The 5- and 10-year estimated OS rates were 100% and 94.1%, respectively. At last evaluation, 53/55 patients (96.4%) had a KPS ≥ 80. A lower risk of relapse was correlated with a smaller preoperative tumor volume ( p = 0.002) and the absence of antiepileptic cover ( p = 0.01). This original data detailing the long-lasting onco-functional outcomes after awake SupTR for IDH-mutated G2G evidenced a prolonged survival with a long-term preservation of quality of life. Such findings support early mapping-based SupTR in awake patients.
Authors
- Hugues Duffau (ORCID: https://orcid.org/0000-0002-6558-2342)
Institutions
- Inserm (FR)
- Hôpital Gui de Chauliac (FR)
Publication Details
- Journal
- Acta Neurochirurgica
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1007/s00701-026-07099-5
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00